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Exercise limitation of hypertrophic cardiomyopathy. The
manifestation of symptoms and exercise intolerance in the
patient with hypertrophic cardiomyopathy represents the
clinical end product of a complex interaction among many of
the pathophysiologic features of this disease. These features
include, among others, reduced coronary vasodilator re-
serve (1-4) and impaired diastolic relaxation and filling of the
hypertrophied left ventricle (3-8). During exertion, these
conditions predispose to myocardial ischemia, a limited
increase in stroke volume and the inability to augment stroke
volume without an exaggerated increase in left ventricular
filling pressures, thereby contributing to symptoms of angina
pectoris, fatigue and dyspnea. In the subset of patients with
outflow tract obstruction, the increased oxygen demands
imposed by the elevated left ventricular systolic pressures
will exacerbate myocardial ischemia and diastolic filling
pressures. Moreover, mitral regurgitation often accompanies
systolic anterior motion of the mitral valve in patients with
obstructive hypertrophic cardiomyopathy (3,4), and this
may further compound the left atrial and pulmonary venous
hypertension. Finally, recent data (9,10) implicate impaired
peripheral vascular responses during exercise as a potential
cause for reduced exercise capacity in some patients.
Considering the multifaceted determinants of exercise
limitation in the individual patient, it would be reasonable to
anticipate that no single clinical index or simple combination
of indexes would be predictive of exercise tolerance in a
series of patients with hypertrophic cardiomyopathy. This
would be the expectation in particular of indexes derived
solely from noninvasive studies performed at rest. On the
other hand, it is also coneivable that indexes of left ventric-
ular systolic and diastolic function under rest conditions may
be influenced by many of the same factors that influence
exercise capacity; certain indexes of ventricular function
might therefore be closely related to the severity of symp-
toms and exercise limitation. The results of the study of
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Chikamori et al., reported in this issue of the Journal (11),
suggest that this may be the case.
The present study. Several of the observations of Chika-
mori et al. (11) are noteworthy. Exercise tolerance, deter-
mined objectively by maximal oxygen consumption, was not
related to the severity of left ventricular hypertrophy in
patients with either obstructive or nonobstructive hyper-
trophic cardiomyopathy. This finding is compatible with
previous observations indicating that patients with even mild
degrees of hypertrophy with this disease may have signifi-
cant diastolic abnormalities and severe symptomatic limita-
tion (12,13). In contrast, several indexes of rest left ventric-
ular function derived from gated radionuclide angiography
were related to exercise capacity. The indexes differed
between patients with and those without an outflow tract
gradient at rest.
Nonobstructive hypertrophic cardiomyopathy. Among pa-
tients with nonobstructive hypertrophic cardiomyopathy,
reduced peak filling rate and prolonged time to end-systole
were the strongest predictors of patients with maximal
oxygen consumption :::;70% of the age-predicted value (11).
In the absence of intracardiac hemodynamic measurements,
the mechanisms responsible for the prolonged ejection time
and reduced filling rate are unclear; hence, the causal
relation between these indexes and exercise intolerance
cannot be determined. The reduced peak filling rate may
reflect impaired ventricular relaxation, which could affect
exercise tolerance by reducing stroke volume and increasing
ventricular filling pressures. This concept is in keeping with
earlier data in patients with hypertrophic cardiomyopathy
indicating that an increase in peak filling rate during vera-
pamil therapy correlates with improved treadmill exercise
capacity (14). However, reduced peak filling rate in the
current study might also represent a diminished left atrial
driving pressure across the mitral valve stemming from
reduced preload; these changes would contribute to exercise
intolerance by lowering ventricular diastolic volume and
stroke volume.
Obstructive hypertrophic cardiomyopathy. In patients in
the current study (11) with outflow tract obstruction, the
magnitude of the left ventricular outflow tract gradient at rest
was not related to maximal oxygen consumption during
exercise. This finding might be debated, because the outflow
tract gradient was estimated by using M-mode echocardiog-
raphy (15). Although the severity and duration of systolic
anterior motion and of mitral valve-septal contact are accu-
rate for identifying the presence of rest outflow obstruction,
their accuracy in measuring the pressure gradient quantita-
tively is questionable. In the absence of direct intracardiac
pressure determinations, Doppler echocardiography would
have provided a more exact and more accepted noninvasive
method with which to quantify the severity of outflow
obstruction (16-18).
Several complex indexes of cardiac function were related
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with a rest outflow tract gradient. These included, 1) an
increased ratio of peak filling rate to peak ejection rate (or
the inverse: a decreased ratio of peak ejection rate to peak
filling rate); 2) a reduction in the relative atrial contribution
to left ventricular stroke volume (or the inverse: an increase
in the relative contribution of rapid diastolic filling to stroke
volume); and 3) a decrease in the atrial contribution to stroke
volume divided by the echocardiographic left atrial dimen-
sion. Chikamori et a1. (11) interpreted these findings as an
indication that systolic failure of both the left ventricle and
the left atrium was the mechanism responsible for reduced
exercise capacity. Earlier data (19) suggest that myocardial
contractility may be depressed in hypertrophic cardiomyop-
athy despite normal or supranormalleft ventricular ejection
performance. This may relate to impaired exercise capacity.
Role of mitral regurgitation. However, there is another
plausible, and very compelling, interpretation of these data,
which would explain the important relation of these three
functional indexes to reduced exercise tolerance in patients
with an outflow tract gradient. This is the effect of mitral
regurgitation. As noted previously, mitral regurgitation (of-
ten of a considerable degree) accompanies outflow obstruc-
tion in the majority of patients (3,4). Mitral regurgitation will
produce precisely the constellation of indexes reported by
Chikamori et a1. (11), namely, an increased peak filling rate
relative to ejection rate, an increased contribution of rapid
diastolic filling to stroke volume with a reduced contribution
of atrial systole, and also a reduced atrial contribution to
stroke volume when this value is divided by the left atrial
dimension. The likelihood that mitral regurgitation, not
ventricular or atrial contractile failure, is a leading determi-
nant of exercise intolerance in patients with an outflow tract
gradient provides additional compelling evidence that there
are fundamental pathophysiologic differences between pa-
tients with and without outflow obstruction. Chikamori et al.
(11) attempted to exclude patients with moderate to severe
mitral regurgitation from the current analysis, but it is
unclear how this determination was made. By auscultation?
This could be very misleading in patients with an obstructive
outflow murmur. There is no indication that these patients
underwent either Doppler echocardiography or left ventric-
ulography to exclude mitral regurgitation. Considering the
severity of the outflow tract gradients reported in Table 4 of
the study (11), one must assume that a large subset of
patients had more than trivial mitral regurgitation.
Limitations of measurements at rest. Although Chikamori
et a1. (11) identified several variables of rest left ventricular
function that were related to exercise intolerance in hyper-
trophic cardiomyopathy, the causal relation between these
variables and exercise capacity cannot be determined from
the available data. Thus, the true mechanisms of exercise
limitation have not been defined. Such mechanisms are
likely to be dynamic in nature and may be poorly reflected in
noninvasive measurements made at rest. For example, it has
been demonstrated (20,21) in other forms of left ventricular
hypertrophy that exercise intolerance may be related to the
inability to augment ventricular end-diastolic volume during
exercise. Similar functional abnormalities may develop dur-
ing exercise in hypertrophic cardiomyopathy (22). More-
over, exercise-induced myocardial ischemia commonly oc-
curs in patients with hypertrophic cardiomyopathy.
Although Chikamori et a1. (11) excluded patients whose
predominant symptom was angina, 42% of their patients
with reduced exercise tolerance had angina with exercise.
Even among asymptomatic patients, >60% develop myocar-
dial ischemia during exercise (23). The dynamic changes in
outflow obstruction and mitral regurgitation during exercise
have not been fully explored. Further studies are needed to
determine whether these and other dynamic mechanisms for
impaired exercise tolerance can be predicted accurately by
noninvasive indexes of hypertrophy and left ventricular
function at rest.
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